The outrage over ISRO's cheap technology transfers misses the point. India does not need a better pricing formula. It needs to accept that technology locked inside a government lab is technology wasted.

A Parliamentary Standing Committee report on the Indian Space Research Organisation (ISRO) transferring technology to the private sector has set off a predictable fury. The committee found that ISRO's commercial arm NSIL has signed 100 technology transfer agreements covering 61 technologies, many at fees below ₹10 lakh. Some went for ₹6,000. A few were transferred at no cost at all. The committee called these prices "disproportionately low relative to their commercial potential".

On social media, the framing was instant. Public assets sold for a song. Taxpayer money subsidising private profit.

The outrage rests on an assumption that deserves scrutiny: that a laser gyroscope validated in an ISRO clean room, or a thermal insulation compound tested on a rocket motor casing, is already delivering value to the Indian public simply by existing inside a government lab. It is not. Technology locked inside a research institution is potential, not value. It becomes value only when somebody manufactures it, builds a supply chain around it, certifies it, finds customers for it, and sells it. That somebody cannot be ISRO.

The same committee report that flagged cheap technology transfers also documented that the Department of Space has 2,817 vacant positions across its centres and units. It managed to utilise only 78 per cent of its Revised Estimates allocation for 2025-26 as of January 2026. The allocation for Chandrayaan-4 was slashed from ₹150 crore at the Budget Estimate stage to ₹21 crore at Revised Estimates because the agency could not spend fast enough. The Venus Orbiter Mission received ₹50 crore and managed to spend ₹5 crore.

This is an agency stretched thin on its core mandate of designing and flying space missions. Asking it to also function as a manufacturing and marketing operation for industrial products is not a serious proposition. Every hour an ISRO scientist spends worrying about commercial pricing is an hour not spent on the next satellite or the next launch vehicle.

So the technology must leave ISRO. The question is at what price. And this is where the outrage goes wrong, because it treats the transfer fee as the return on public investment. It is not.

The return on public investment comes from what happens after the transfer. It comes from the Indian company that starts manufacturing a product domestically instead of importing it. It comes from the jobs created, the supply chains built, the tax revenues generated, and the strategic capability gained when Indian industry can produce a ceramic servo accelerometer or an X-band synthetic aperture radar without depending on a foreign vendor. A ₹6,000 transfer fee that results in an Indian company building distress alert transmitters for fishermen returns more to the Indian public than a ₹6 lakh fee that ensures the technology never leaves the laboratory.

The critics assume that these technologies have guaranteed commercial value. They do not. A private firm receiving a technology transfer is not buying a finished product. It is buying a starting point. The firm must then invest its own capital in tooling, production engineering, quality systems, regulatory compliance, market development, and customer acquisition. The distance between what works in a government lab and what works as a commercial product is enormous. Not every transferred technology will find a market. Not every company that licenses an ISRO patent will succeed.

The firms absorbing these technologies are, in most cases, not large corporations extracting windfall profits. The actual recipients are companies like Bhukhanvala Industries, Anabond Limited, BHOR Chemicals and Plastics, VND Cell Plast, and Pushpak Industrial Services. They are licensing phenolic resins, rubber compounds, flameproofing coatings, and black anodisation processes on aluminium alloys.

These are niche industrial materials with small addressable markets and uncertain commercial outcomes. The committee's assertion that private players earn "significant profits" from cheaply transferred technologies is not supported by any evidence it has itself presented.

Where transfers do involve strategically significant technologies, the pricing already reflects it. The ISRO Laser Gyro went to Zetatek Technologies at ₹1.87 crore. The MiniSAR X-band Airborne SAR went to three different companies at ₹52.6 lakh each. SSLV technology went to HAL at ₹511 crore. The system already differentiates. It is not as uniformly broken as the headlines suggest.

There is another dimension the debate ignores entirely. Technology depreciates. A propulsion material that is cutting-edge today will be obsolete in a decade. A satellite bus architecture that represents ISRO's best work in 2020 will be overtaken by newer designs well before 2030. If the government sits on its intellectual property waiting for a buyer willing to pay "true commercial value," the window of relevance closes. The technology becomes worthless not because someone transferred it too cheaply but because nobody transferred it at all.

The report lists 100 transfers over five years. That is 20 per year for an agency that has been developing space technologies for over five decades. The real scandal is not that ISRO transfers too cheaply. The real scandal is that it transfers too slowly, and hundreds of publicly funded technologies remain locked inside ISRO centres with no commercial pathway whatsoever.

This is how space powers are built

None of this is uniquely Indian. The country that has benefited most from aggressive, low-cost technology transfer from government labs to the private sector is the United States.

In 1980, the US federal government held roughly 30,000 patents. Fewer than 5 per cent had been commercialised. Taxpayer-funded inventions sat in agency filing cabinets doing nothing for the taxpayers who funded them. The US Congress responded not by raising prices but by making transfer easier.

Starting in 1980, Congress passed a series of laws that together created a single institutional posture. Universities and labs that developed inventions with federal money could keep the patents and licence them to private firms. Every federal laboratory was required to actively participate in technology transfer, not as a favour but as a mandate. Joint R&D agreements between government labs and private companies were formalised. Private partners were guaranteed enough intellectual property rights to make commercialisation worth their investment. The government kept the right to step in if a licensee failed to act, but that was the exception.

The default posture of the entire system was transfer, not hoarding.

Over four decades, the framework put in place by the US government contributed over $1.3 trillion to the country's economic growth, created more than 4.2 million jobs, and spawned over 11,000 startup companies from universities alone.

NASA operates under the most explicit transfer mandate of any US federal agency. Its founding legislation from 1958 contains a Congressional directive to ensure that technologies created for space exploration benefit all of humanity.

The scale is substantial. NASA has about 1,500 active patents, of which about 1,100 are available for licensing. In fiscal year 2021, it signed over 200 patent licence agreements, the most in its history. It also runs a formal startup licensing programme. A Startup Licence waives annual fees for up to three years, after which companies pay a $3,000 annual fee and a flat 4.2 per cent royalty on products sold.